Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer
Public ClinicalTrials.gov record NCT00985192. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Study of the mTOR Inhibitor RAD001 in Previously Treated Patients With Unresectable or Metastatic Adenocarcinoma of the Esophagus and Stomach
Study identification
- NCT ID
- NCT00985192
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Translational Oncology Research International
- Other
- Enrollment
- 49 participants
Conditions and interventions
Conditions
Interventions
- everolimus Drug
- laboratory biomarker analysis Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2009
- Primary completion
- Apr 30, 2014
- Completion
- Apr 30, 2014
- Last update posted
- Aug 4, 2020
2009 – 2014
United States locations
- U.S. sites
- 18
- U.S. states
- 3
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Central Hematology Oncology Medical Group, Inc. | Alhambra | California | 91801 | — |
| Comprehensive Blood and Cancer Center | Bakersfield | California | 93309 | — |
| St. Jude Heritage Medical Group at Virginia K. Crosson Cancer Center | Fullerton | California | 92835 | — |
| Antelope Valley Cancer Center | Lancaster | California | 93534 | — |
| Pacific Shores Medical Group | Long Beach | California | 90813 | — |
| Jonsson Comprehensive Cancer Center at UCLA | Los Angeles | California | 90095-1781 | — |
| Translational Oncology Research International (TORI) Network | Los Angeles | California | 90095 | — |
| North Valley Hematology/Oncology Medical Group | Northridge | California | 91328 | — |
| Wilshire Oncology Medical Group, Inc. | Pomona | California | 91767 | — |
| Cancer Care Associates Medical Group, Inc. | Redondo Beach | California | 90277 | — |
| TORI REDONDO BEACH (Cancer Care Associates Medical Group, Inc.) | Redondo Beach | California | 90277 | — |
| Sansum Medical Clinic | Santa Barbara | California | 93105 | — |
| Santa Barbara Hematology Oncology Medical Group, Inc. | Santa Barbara | California | 93105 | — |
| Central Coast Medical Oncology Corporation | Santa Maria | California | 93454 | — |
| Trivalley Oncology Hematology | Westlake Village | California | 91361 | — |
| Suburban Hematology-Oncology Associates, P.A. | Lawrenceville | Georgia | 30045 | — |
| Northwest Georgia Oncology Centers, P.C. | Marietta | Georgia | 30060 | — |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00985192, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 4, 2020 · Synced May 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00985192 live on ClinicalTrials.gov.